Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter

Gene Therapy

Volumn 3, Issue 12, 1996, Pages 1094-1103

  Ring, C J A ^a,b   Harris, J D ^a,c   Hurst, H C ^a   Lemoine, N R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conditional expression; ERBB2 promoter; Suicide gene; Viral vectors

Indexed keywords

BETA GALACTOSIDASE; GANCICLOVIR; PLASMID VECTOR; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CODON; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; GENETIC ENGINEERING; GENOME; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROMOTER REGION; SUICIDE GENE; TUMOR CELL;

ADENOVIRIDAE; ADENOVIRUS E3 PROTEINS; ANTIMETABOLITES, ANTINEOPLASTIC; BIOTRANSFORMATION; CELL LINE; CLONING, MOLECULAR; DRUG RESISTANCE; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; PLASMIDS; PRODRUGS; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; RETROVIRIDAE; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0030459592     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gutierrez AA, Lemoine NR, Sikora K. Gene therapy for cancer Lancet 1992; 339: 715-721.
2. Slamon DJ et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182.
3. Hall PA et al. The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 1990; 161: 195-200.
4. Lemoine NR et al. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br J Cancer 1991; 64: 79-83.
5. Harris JD et al. Gene therapy for cancer using tumour-specific prodrug activation. Gene Therapy 1994, 1: 170-175.
6. Ali M, Lemoine NR, Ring CJA. The use of DNA viruses as vectors for gene therapy. Gene Therapy 1994; 1: 367-384.
7. Ring CJA. Adenovirus vectors. In: Lemoine NR, Cooper DN (eds). Gene Therapy, βios: Oxford, 1996, pp 61-76.
8. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.
9. Wilkinson GWG, Akrigg A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 1992; 20: 2233-2239.
10. Hearing P, Shenk T. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell 1983; 33: 695-703.
11. Hearing P, Shenk T. The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis. Cell 1986; 45: 229-236.
12. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
13. Bout A et al. In vivo adenovirus-mediated transfer of human CFTR cDNA to Rhesus monkey airway epithelium: efficacy, toxicity and safety. Gene Therapy 1994; 1: 385-394.
14. Grable M, Hearing P. Cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J Virol 1992; 66: 723-731.
15. Mittal SH, Bett AJ, Prevec L, Graham FL. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial β-galactosidase genes as reporters. Virology 1995; 210: 226-230.
16. Imler J-L et al. Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter. Gene Therapy 1996; 3: 49-58.
17. Connelly S, Gardner JM, McClelland A, Kaleko M. High level tissue-specific expression of functional human factor VIII in mice. Hum Gene Ther 1996; 7: 183-195.
18. Hashimoto M et al. A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum Gene Ther 1996; 7: 149-158.
19. Kaneko S et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 1995; 55: 5283-5287.
20. Wills KN et al. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther 1995; 3: 191-197.
21. Arbuthnot PB et al. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Human Gene Ther 1996; 7: 1503-1514.
22. Chen L et al. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J Clin Invest 1995; 96: 2775-2782.
23. Saito I et al. Construction of non-defective adenovirus type 5 bearing a 2.8-kilobase Hepatitis B virus DNA near the right end if its genome. J Virol 1985; 54: 711-719.
24. Wolffe AP. Insulating chromatin. Curr Biol 1994; 4: 85-87.
25. Kellum R, Schedl P. A group of scs elements function as domain boundaries in an enhancer-blocking assay. Mol Cell Biol 1992; 12: 2424-2431.
26. Hollywood DP, Hurst HC. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J 1993; 12: 2369-2375.
27. Hitt M, Bett AJ, Prevec L, Graham FL. Construction and propagation of human adenovirus vectors. In: Celis JE (ed). Cell Biology: A Laboratory Handbook. Academic Press; New York, 1995.
28. McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988; 163: 614-617.
29. Bramson J et al Construction of a double recombinant adeno-virus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Ther 1996; 7: 333-342.
30. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91: 8802-8806.
31. Hantzopoulos PE, Sullenger BA, Ungers G, Gilboa E. Improved expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 1989; 86: 3519-3523.
32. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988; 167: 400-406.
33. Bett AJ, Krougliak V, Graham FL. DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309. Virus Res 1995; 39: 75-82.